export interface Article {
  slug: string
  title: string
  dek: string
  category: "Pharma" | "MedTech" | "AI-Health"
  format: "Feature" | "Analysis" | "Interview" | "Digest"
  issueId: string
  authorId: string
  date: string
  readingTime: string
  tags: string[]
  image: string
  body: string[]
  isLocked?: boolean
}

export const ARTICLES: Article[] = [
  {
    slug: "continuous-biomanufacturing-cdmo-scaleup-2026",
    title: "Continuous Biomanufacturing at Scale: How Indian CDMOs Are Accelerating APAC Biologics",
    dek: "A deep dive into perfusion bioreactor economics, single-use technology adoption, and regulatory validation for commercial biologic APIs.",
    category: "Pharma",
    format: "Feature",
    issueId: "issue-2026-09",
    authorId: "auth-arun-sharma",
    date: "Sep 02, 2026",
    readingTime: "8 min read",
    tags: ["Bioprocessing", "CDMO Operations", "Biologics API"],
    image: "https://images.unsplash.com/photo-1581093458791-9f3c3250a8b0?auto=format&fit=crop&w=1200&q=80",
    body: [
      "As global pharmaceutical developers seek to diversify biomanufacturing supply chains away from single-geography risks, leading Indian Contract Development and Manufacturing Organizations (CDMOs) are investing heavily in continuous bioprocessing facilities.",
      "Perfusion bioreactors and automated downstream purification lines are significantly reducing footprint requirements while enhancing batch-to-batch consistency for complex monoclonal antibodies (mAbs) and biosimilars.",
      "Regulatory bodies including the USFDA and EMA are working alongside CDSCO to harmonize continuous manufacturing validation guidelines, creating faster market pathways for high-titer commercial biologics."
    ],
    isLocked: false,
  },
  {
    slug: "ai-generative-protein-design-regulatory",
    title: "Generative AI in De Novo Protein Engineering: Regulatory Validation Benchmarks",
    dek: "Evaluating computational protein folding models, wet-lab validation loops, and IND filing standards for AI-designed therapies.",
    category: "AI-Health",
    format: "Analysis",
    issueId: "issue-2026-09",
    authorId: "auth-priya-nair",
    date: "Aug 28, 2026",
    readingTime: "6 min read",
    tags: ["Generative AI", "Protein Engineering", "Regulatory Affairs"],
    image: "https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Generative artificial intelligence has dramatically accelerated candidate selection in therapeutic protein design. However, transitioning these molecules from in silico predictions to clinical-grade drug candidates requires rigorous experimental benchmarking.",
      "Regulatory reviewers now demand detailed audit trails of training datasets, structural stability profiles, immunogenicity scoring, and off-target screening protocols prior to approving Investigational New Drug (IND) applications."
    ],
    isLocked: true,
  },
  {
    slug: "cdsco-ai-diagnostics-framework-2026",
    title: "CDSCO's 2026 AI Diagnostics Framework: What Regulatory Leads Need to Know",
    dek: "A detailed breakdown of new validation mandates, software-as-a-medical-device (SaMD) requirements, and clinical trial audit expectations.",
    category: "AI-Health",
    format: "Feature",
    issueId: "issue-2026-08",
    authorId: "auth-priya-nair",
    date: "Aug 15, 2026",
    readingTime: "7 min read",
    tags: ["Regulatory Affairs", "AI Diagnostics", "Clinical Operations"],
    image: "https://images.unsplash.com/photo-1576086213369-97a306d36557?auto=format&fit=crop&w=1200&q=80",
    body: [
      "The Central Drugs Standard Control Organisation (CDSCO) has introduced revised guidelines for AI-assisted diagnostic tools, bringing software-as-a-medical-device (SaMD) oversight into closer alignment with global standards.",
      "For regulatory affairs leaders in India and the wider APAC region, this shift requires a multi-layered approach to clinical evidence collection, real-world data validation, and ongoing post-market surveillance.",
      "Key changes focus on algorithm explainability, training data diversity representative of local patient populations, and continuous performance monitoring protocols."
    ],
    isLocked: false,
  },
  {
    slug: "surgical-robotics-ip-licensing-apac",
    title: "Navigating IP & Licensing Partnerships for Next-Gen Surgical Platforms",
    dek: "How MedTech innovators are structuring co-development agreements across emerging APAC manufacturing hubs.",
    category: "MedTech",
    format: "Analysis",
    issueId: "issue-2026-08",
    authorId: "auth-marcus-ob",
    date: "Aug 10, 2026",
    readingTime: "5 min read",
    tags: ["Surgical Robotics", "IP & Strategy", "Supply Chain"],
    image: "https://images.unsplash.com/photo-1581091226825-a6a2a5aee158?auto=format&fit=crop&w=1200&q=80",
    body: [
      "The rapid expansion of robotic-assisted surgical platforms across South and Southeast Asia has created new opportunities for technology licensing and strategic cross-border partnerships.",
      "Early-stage device manufacturers must navigate complex patent clearance procedures while securing local manufacturing partners capable of meeting international precision standards."
    ],
    isLocked: false,
  },
  {
    slug: "mrna-cold-chain-logistics-tier2",
    title: "mRNA Therapeutics & Cold-Chain Realities in Tier-2 Distribution",
    dek: "Operational strategies for maintaining ultracold storage integrity across decentralized health networks.",
    category: "Pharma",
    format: "Interview",
    issueId: "issue-2026-08",
    authorId: "auth-arun-sharma",
    date: "Aug 05, 2026",
    readingTime: "6 min read",
    tags: ["mRNA Platforms", "Supply Chain", "Market Access"],
    image: "https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Distributing mRNA vaccines and gene therapies beyond metro centers remains one of the most pressing supply chain challenges facing pharmaceutical operations today.",
      "Innovative packaging solutions and IoT-enabled temperature sensors are enabling real-time monitoring, reducing product wastage and expanding reach into regional distribution hubs."
    ],
    isLocked: true,
  },
  {
    slug: "car-t-manufacturing-decentralized-hubs",
    title: "Decentralized Point-of-Care CAR-T Cell Therapy Manufacturing",
    dek: "Evaluating closed-system automated cell processing units in tertiary oncology centers.",
    category: "Pharma",
    format: "Feature",
    issueId: "issue-2026-07",
    authorId: "auth-vikram-malhotra",
    date: "Jul 18, 2026",
    readingTime: "9 min read",
    tags: ["Cell Therapy", "CAR-T", "Oncology"],
    image: "https://images.unsplash.com/photo-1579154204601-01588f351e67?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Point-of-care CAR-T cell processing is reshaping the economic landscape of personalized autologous cancer immunotherapy.",
      "By utilizing automated benchtop cell engineering devices inside certified hospital cleanrooms, treatment turnaround times can be reduced from 4 weeks to under 7 days."
    ],
    isLocked: false,
  },
  {
    slug: "companion-diagnostics-payer-models",
    title: "Companion Diagnostics: Building Payer Evidence Frameworks in Oncology",
    dek: "Why health economics outcomes research (HEOR) must be integrated at early clinical development phases.",
    category: "Pharma",
    format: "Analysis",
    issueId: "issue-2026-08",
    authorId: "auth-leila-ahmadi",
    date: "Jul 28, 2026",
    readingTime: "8 min read",
    tags: ["Companion Diagnostics", "Oncology BD", "Health Economics"],
    image: "https://images.unsplash.com/photo-1576091160550-2173dba999ef?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Securing market access for novel companion diagnostic tests requires demonstrating tangible economic value alongside clinical efficacy.",
      "Collaborative models between diagnostic developers and pharmaceutical sponsors are demonstrating faster regulatory clearance and improved market uptake."
    ],
    isLocked: false,
  },
  {
    slug: "ai-pharmacovigilance-signal-detection",
    title: "Automating Signal Detection: AI Pipelines in Modern Pharmacovigilance",
    dek: "Practical implementation approaches for NLP models parsing multi-lingual adverse event reporting.",
    category: "AI-Health",
    format: "Digest",
    issueId: "issue-2026-08",
    authorId: "auth-siddharth-rao",
    date: "Jul 20, 2026",
    readingTime: "4 min read",
    tags: ["Pharmacovigilance", "AI Diagnostics", "Regulatory Affairs"],
    image: "https://images.unsplash.com/photo-1507679799987-c73779587ccf?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Natural language processing models are transforming how safety teams aggregate and triage potential safety signals from clinical literature and spontaneous reporting systems."
    ],
    isLocked: false,
  },
  {
    slug: "smart-packaging-temperature-telemetry",
    title: "Smart Packaging & Real-Time Temperature Telemetry in Biologics Logistics",
    dek: "How phase-change materials and Bluetooth low-energy data loggers protect temperature-sensitive APIs.",
    category: "Pharma",
    format: "Feature",
    issueId: "issue-2026-06",
    authorId: "auth-marcus-ob",
    date: "Jun 14, 2026",
    readingTime: "6 min read",
    tags: ["Smart Packaging", "Cold Chain", "Supply Chain"],
    image: "https://images.unsplash.com/photo-1586528116311-ad8dd3c8310d?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Maintaining cold-chain compliance throughout transit requires seamless integration of passive thermal insulation and active sensor monitoring.",
      "Logistics providers are adopting IoT telemetry nodes that transmit live temperature, humidity, and tilt alerts to cloud dashboards, allowing immediate intervention prior to product loss."
    ],
    isLocked: false,
  },
  {
    slug: "nextgen-sequencing-liquid-biopsy",
    title: "Liquid Biopsy & Circulating Tumor DNA in Early Cancer Screening",
    dek: "Clinical trial outcomes, assay sensitivity benchmarks, and reimbursement trends for NGS liquid biopsy assays.",
    category: "MedTech",
    format: "Feature",
    issueId: "issue-2026-05",
    authorId: "auth-leila-ahmadi",
    date: "May 22, 2026",
    readingTime: "7 min read",
    tags: ["Liquid Biopsy", "NGS", "Oncology Diagnostics"],
    image: "https://images.unsplash.com/photo-1530497610245-94d3c16cda28?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Non-invasive liquid biopsies isolating circulating tumor DNA (ctDNA) offer unprecedented sensitivity in monitoring minimal residual disease and early cancer relapse.",
      "Leading clinical labs are expanding multi-gene panel coverage to provide actionable genomic profiles within 5 days of blood collection."
    ],
    isLocked: true,
  },
  {
    slug: "haptic-feedback-robotic-surgery-training",
    title: "Haptic Sensing & Augmented Reality in Robotic Surgical Training",
    dek: "Bridging the tactile gap in remote tele-surgery through micro-sensor arrays and digital twin simulation.",
    category: "MedTech",
    format: "Interview",
    issueId: "issue-2026-04",
    authorId: "auth-vikram-malhotra",
    date: "Apr 19, 2026",
    readingTime: "5 min read",
    tags: ["Surgical Robotics", "Augmented Reality", "MedTech"],
    image: "https://images.unsplash.com/photo-1516549655169-df83a0774514?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Recreating true tactile force-feedback in robotic surgical master consoles remains a breakthrough frontier for complex soft-tissue procedures.",
      "Advanced haptic actuators paired with low-latency 5G networks allow surgeons to feel tissue elasticity, enhancing safety during delicate oncological resections."
    ],
    isLocked: false,
  },
  {
    slug: "biosimilar-interchangeability-usfda-cdsco",
    title: "Biosimilar Interchangeability Standards: Comparative Regulatory Pathways",
    dek: "Analyzing switching study design requirements, analytical similarity testing, and market entry timelines.",
    category: "Pharma",
    format: "Digest",
    issueId: "issue-2026-09",
    authorId: "auth-priya-nair",
    date: "Sep 01, 2026",
    readingTime: "4 min read",
    tags: ["Biosimilars", "Regulatory Affairs", "Pharma BD"],
    image: "https://images.unsplash.com/photo-1585435557343-3b092031a831?auto=format&fit=crop&w=1200&q=80",
    body: [
      "Regulatory alignment on biosimilar interchangeability designation is streamlining substitution policies at retail and hospital pharmacy levels globally.",
      "Comprehensive analytical characterization and post-marketing surveillance are reducing reliance on lengthy clinical switching studies."
    ],
    isLocked: false,
  },
]

